Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
PTC Therapeutics, Inc. (PTCT)  
$33.62 0.54 (1.58%) as of 4:30 Thu 5/2


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 90,552,000
Market Cap: 3.04(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.07 - $59.1
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 8
Insider 3/6 Months : 8.6
Guru Rank Number :  538
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna™ (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 7,700 7,700 7,700
Total Buy Value $0 $198,736 $198,736 $198,736
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 5,981 52,172 114,858 280,340
Total Sell Value $151,224 $1,447,501 $4,819,149 $12,887,777
Total People Sold 3 8 10 15
Total Sell Transactions 4 26 35 88
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 524
  Page 2 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2024-01-30 4 S $27.25 $763 I/I (28) 3,706 -29%     
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2024-01-30 4 S $27.25 $16,841 D/D (618) 61,202 -29%     
   Jacobson Allan Steven   –       •      –    2024-01-22 4 AS $27.38 $273,804 D/D (10,000) 12,348 5%     
   Jacobson Allan Steven   –       •      –    2024-01-22 4 OE $27.05 $270,500 D/D 10,000 22,348     -
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2024-01-09 4 S $29.01 $2,901 I/I (100) 3,734 -19%     
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2024-01-09 4 S $29.01 $44,132 D/D (1,521) 61,820 -19%     
   Pauwels Eric CHIEF BUSINESS OFFICER   •       –      –    2024-01-09 4 S $29.01 $59,916 D/D (2,065) 44,547 -19%     
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2024-01-09 4 S $29.01 $157,928 D/D (5,443) 160,475 -19%     
   Utter Christine Marie SVP, FINANCE & CAO   •       –      –    2024-01-09 4 S $29.01 $47,961 D/D (1,653) 35,846 -19%     
   Golden Lee Scott CHIEF MEDICAL OFFICER   •       –      –    2024-01-09 4 S $29.01 $35,543 D/D (1,225) 37,914 -19%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2024-01-09 4 S $29.01 $56,231 D/D (1,938) 71,983 -19%     
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2024-01-08 4 S $28.64 $1,518 I/I (53) 3,834 -14%     
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2024-01-08 4 S $28.64 $35,399 D/D (1,236) 63,341 -14%     
   Schmertzler Michael   –       •      –    2024-01-08 4 AS $27.81 $41,715 D/D (1,500) 115,266 -5%     
   Pauwels Eric CHIEF BUSINESS OFFICER   •       –      –    2024-01-08 4 S $28.64 $44,937 D/D (1,569) 46,612 -14%     
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2024-01-08 4 S $28.64 $64,068 D/D (2,237) 165,918 -14%     
   Utter Christine Marie SVP, FINANCE & CAO   •       –      –    2024-01-08 4 S $28.64 $34,025 D/D (1,188) 37,499 -14%     
   Golden Lee Scott CHIEF MEDICAL OFFICER   •       –      –    2024-01-08 4 S $28.64 $22,196 D/D (775) 39,139 -14%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2024-01-08 4 S $28.64 $41,729 D/D (1,457) 73,921 -14%     
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2024-01-05 4 S $27.15 $274,393 D/D (10,107) 168,155 -22%     
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2023-12-28 4 A $0.00 $0 D/D 75,000 177,961     -
   Gravier Pierre CHIEF FINANCIAL OFFICER   •       –      –    2023-12-12 4 B $25.81 $198,736 D/D 7,700 33,700 0.01 -3%     
   Young Alethia   –       •      –    2023-09-06 4 S $39.79 $464,972 D/D (11,666) 9,067 29%     
   Young Alethia   –       •      –    2023-09-06 4 OE $27.85 $324,898 D/D 11,666 13,733     -
   Gravier Pierre CHIEF FINANCIAL OFFICER   •       –      –    2023-07-13 4 A $0.00 $0 D/D 26,000 26,000     -
  524 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us